PROGNOSTIC INDICATORS FOR FAILURE OF SURVEILLANCE MANAGEMENT OF STAGE-I NON-SEMINOMATOUS GERM-CELL TUMORS

被引:17
|
作者
COSTELLO, AJ
MORTENSEN, PH
STILLWELL, RG
机构
来源
关键词
D O I
10.1111/j.1445-2197.1989.tb01480.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:119 / 122
页数:4
相关论文
共 50 条
  • [41] Outcomes of surveillance VS. adjuvant chemotherapy for patients with STAGE IA and IB NON-seminomatous testicular germ-cell tumors.
    Bilici, Ahmet
    Gumus, Mahmut
    Odabas, Hatice
    Kandemir, Nurten
    Demirci, Umut
    Cihan, Sener
    Bayoglu, Ibrahim Vedat
    Ustaalioglu, Bala Basak Oven
    Ozturk, Turkan
    Turkmen, Esma
    Urakci, Zuhat
    Seker, Mehmet Metin
    Gunaydin, Yusuf
    Selcukbiricik, Fatih
    Turan, Nedim
    Sevinc, Alper
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [42] TREATMENT OF NON-SEMINOMATOUS TESTICULAR-TUMORS (TNST) - STAGE-I AND STAGE-II
    METZ, R
    CAROLUS, JM
    WEBER, B
    CAROLUS, J
    KRAKOWSKI, I
    BULLETIN DU CANCER, 1984, 71 (03) : 246 - 246
  • [43] TREATMENT OF STAGE-I NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTICLE
    DROZ, JP
    PRESSE MEDICALE, 1995, 24 (32): : 1501 - 1503
  • [44] PROGNOSIS FOR PATHOLOGIC STAGE-1 NON-SEMINOMATOUS GERM-CELL TUMORS OF TESTIS MANAGED BY RETROPERITONEAL LYMPHADENECTOMY
    JOHNSON, DE
    BRACKEN, RB
    BLIGHT, EM
    JOURNAL OF UROLOGY, 1976, 116 (01): : 63 - 65
  • [45] SINGLE AGENT ACTIVITY OF METHOTREXATE IN ADVANCED NON-SEMINOMATOUS TESTICULAR GERM-CELL TUMORS
    SMITH, DB
    RUSTIN, GJS
    HITCHINS, R
    BAGSHAWE, KD
    HOSKINS, P
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (11): : 1779 - 1781
  • [46] NON-SEMINOMATOUS GERM-CELL TESTICULAR-TUMORS - RESIDUAL MASSES AFTER CHEMOTHERAPY
    LEVITT, MD
    REYNOLDS, PM
    SHEINER, HJ
    BYRNE, MJ
    BRITISH JOURNAL OF SURGERY, 1985, 72 (01) : 19 - 22
  • [47] DRUG-THERAPY IN NON-SEMINOMATOUS GERM-CELL CANCERS OF TESTIS STAGE-A
    EKMAN, P
    EDSMYR, F
    ALMGARD, LE
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1978, : 31 - 31
  • [48] Multicentre risk-adapted management for stage I non-seminomatous germ cell tumours
    Maroto, P
    del Muro, XG
    Aparicio, J
    Paz-Ares, L
    Arranz, JA
    Guma, J
    Terrassa, J
    Barnadas, J
    Dorta, J
    Germà-Lluch, JR
    ANNALS OF ONCOLOGY, 2005, 16 (12) : 1915 - 1920
  • [49] SURVEILLANCE-ONLY POLICY IN CLINICAL STAGE-I NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS
    TEKGUL, S
    OZEN, H
    OZGU, I
    SAHIN, A
    ERGEN, A
    REMZI, D
    BULLETIN DU CANCER, 1995, 82 (02) : 162 - 166
  • [50] Surveillance after complete response in patients with metastatic non-seminomatous germ-cell tumor (NSGCT).
    King, Jennifer
    Althouse, Sandra K.
    Cary, Clint
    Masterson, Timothy A.
    Foster, Richard
    Ashkar, Ryan
    Hanna, Nasser H.
    Einhorn, Lawrence H.
    Adra, Nabil
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)